Therefore, after tirzepatide was approved for marketing, Eli Lilly, relying on the market foundation of dulaglutide, fully integrated its successful experience and commercialization resources
Nestl has also developed a complementary digital marketing strategy that positions Vital Pursuit as a "brand to support GLP-1 users," connecting their products to weight-loss medications
On the contrary, the stable clone and wild type did not show any significant difference in their susceptibility towards doxorubicin (3 g/ml)- or radiation (0.21 Gy)-induced cell death
The parallel SURMOUNT-2 cohort with type 2 diabetes lost roughly 67 percentage points less on the same dose
Further studies can be carried out to confirm the long-term safety of nasal formulation
Nausea occurs in approximately 28% of users, with diarrhea affecting 24% and vomiting appearing in 17%